**UnitedHealth Group (UNH)**:
* Unitedhealth Group Inc is a equity in the USA market.
* The price is 307.42 USD currently with a change of 3.99 USD (0.01%) from the previous close.
* The latest open price was 304.96 USD and the intraday volume is 14930045.
* The intraday high is 310.57 USD and the intraday low is 303.9 USD.
* The latest trade time is Saturday, August 23, 03:57:37 +0400.
---
### Key Highlights:
* **Current Price**: Approximately **\$307.42**, reflecting a **1.34% increase** from the previous close ([StockAnalysis][1], [MarketWatch][2]).
* **Daily Range**: Between **\$303.90** and **\$310.57**, with an opening price around **\$304.96** .
* **Volume**: Around **14.93 million shares**, close to the platform-reported figure ([MarketWatch][3]).
* **52-Week Range**: From a low of **\$234.60** to a high of **\$630.73** ([StockAnalysis][1]).
* **Analyst Ratings**:
* Consensus: **Buy**
* Average Price Target: **\$397.78**, implying \~29% upside potential ([StockAnalysis][1]).
---
### Recent Developments & Insights:
* **Berkshire Hathaway Boosts Confidence**
Warren Buffett’s Berkshire Hathaway recently acquired **5 million shares** of UNH, sparking a \~14% rally in the stock, signaling confidence in its long-term potential despite recent underperformance ([Barron's][4]).
* **Medicare Advantage Headwinds**
Analysts, including those at Bank of America, caution that changes to the Medicare Advantage rating system and reimbursements may pressure UnitedHealth’s profitability through 2028. A recent **5.06% increase** in reimbursement rates offers some optimism, but potential coding changes remain a significant risk ([Barron's][4]).
* **Mixed Market Context**
On August 22, UNH rose 1.34% to **\$307.42**, compared to Humana (+1.71%) and Elevance Health (+2.24%) ([MarketWatch][2]). The previous day (Aug 21), UNH climbed 1.17% to **\$303.35**, outperforming Elevance and Chubb, though Humana still led the gains ([MarketWatch][5]).
---
### Quick Summary Table
| Item | Details |
| --------------------- | -------------------------------- |
| **Current Price** | \~\$307.42 |
| **Intraday Range** | \~\$303.90 – \~\$310.57 |
| **Volume** | \~14.9M shares |
| **52-Week Range** | \$234.60 – \$630.73 |
| **Analyst Sentiment** | Buy, Target: \~\$397.78 |
| **Recent Driver** | Berkshire Hathaway purchase |
| **Risks Ahead** | Medicare Advantage policy shifts |
---
### What Would You Like Next?
Want to dive deeper? I can pull up:
* Upcoming **earnings dates and forecasts**
* **Dividend history** and yield trends
* **Historical performance charts**
* Or compare UNH against its healthcare peers like Humana or Elevance Health
Just let me know where you'd like to go next!
* Unitedhealth Group Inc is a equity in the USA market.
* The price is 307.42 USD currently with a change of 3.99 USD (0.01%) from the previous close.
* The latest open price was 304.96 USD and the intraday volume is 14930045.
* The intraday high is 310.57 USD and the intraday low is 303.9 USD.
* The latest trade time is Saturday, August 23, 03:57:37 +0400.
---
### Key Highlights:
* **Current Price**: Approximately **\$307.42**, reflecting a **1.34% increase** from the previous close ([StockAnalysis][1], [MarketWatch][2]).
* **Daily Range**: Between **\$303.90** and **\$310.57**, with an opening price around **\$304.96** .
* **Volume**: Around **14.93 million shares**, close to the platform-reported figure ([MarketWatch][3]).
* **52-Week Range**: From a low of **\$234.60** to a high of **\$630.73** ([StockAnalysis][1]).
* **Analyst Ratings**:
* Consensus: **Buy**
* Average Price Target: **\$397.78**, implying \~29% upside potential ([StockAnalysis][1]).
---
### Recent Developments & Insights:
* **Berkshire Hathaway Boosts Confidence**
Warren Buffett’s Berkshire Hathaway recently acquired **5 million shares** of UNH, sparking a \~14% rally in the stock, signaling confidence in its long-term potential despite recent underperformance ([Barron's][4]).
* **Medicare Advantage Headwinds**
Analysts, including those at Bank of America, caution that changes to the Medicare Advantage rating system and reimbursements may pressure UnitedHealth’s profitability through 2028. A recent **5.06% increase** in reimbursement rates offers some optimism, but potential coding changes remain a significant risk ([Barron's][4]).
* **Mixed Market Context**
On August 22, UNH rose 1.34% to **\$307.42**, compared to Humana (+1.71%) and Elevance Health (+2.24%) ([MarketWatch][2]). The previous day (Aug 21), UNH climbed 1.17% to **\$303.35**, outperforming Elevance and Chubb, though Humana still led the gains ([MarketWatch][5]).
---
### Quick Summary Table
| Item | Details |
| --------------------- | -------------------------------- |
| **Current Price** | \~\$307.42 |
| **Intraday Range** | \~\$303.90 – \~\$310.57 |
| **Volume** | \~14.9M shares |
| **52-Week Range** | \$234.60 – \$630.73 |
| **Analyst Sentiment** | Buy, Target: \~\$397.78 |
| **Recent Driver** | Berkshire Hathaway purchase |
| **Risks Ahead** | Medicare Advantage policy shifts |
---
### What Would You Like Next?
Want to dive deeper? I can pull up:
* Upcoming **earnings dates and forecasts**
* **Dividend history** and yield trends
* **Historical performance charts**
* Or compare UNH against its healthcare peers like Humana or Elevance Health
Just let me know where you'd like to go next!
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.